CD8A and hepatocellular carcinoma: Manipulating TAM polarization towards an antitumoral phenotype, reducing immunosuppressive TAMs, or enhancing CD8+ T cell function by disrupting TAM-mediated suppression shows potential for enhancing HCC treatment strategies.